___

• 1. Grossman S, Labedzki D, Butcher R, Dellea L. Definition and management of anxiety, agitation, and confusion in ICUs. Nursingconnections 1996;9(2):49–55. 2. Wang J, Peng Z-Y, Zhou W-H, Hu B, Rao X, Li J-G. A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China. Chin Med J (Engl) 2017;130(10):1182. 3. Mansouri P, Javadpour S, Zand F, Ghodsbin F, Sabetian G, Masjedi M, et al. Implementation of a protocol for integrated management of pain, agitation, and delirium can improve clinical outcomes in the intensive care unit: A randomized clinical trial. J Crit Care 2013;28(6):918–22. 4. J. A, F. G, A. B, M. L. The agents used for sedation in neurointensive care unit. Ann Fr Anesth Reanim 2004;23(5):528–34. 5. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: A randomised, open-label, pharmacoeconomic trial. Crit Care 2006;10(3). 6. Muellejans B, López A, Cross MH, Bonome C, Morrison L, Kirkham AJT. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized double-blind controlled tria. Crit Care 2004;8(1):R1–11 7. Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation. N Engl J Med 2000;342:1471–7. 8. BERRY CB, GILLESPIE T, HOOD J, SCOTT NB. Growth of micro‐organisms in solutions of intravenous anaesthetic agents. Anaesthesia 1993;48(1):30–2. 9. Langevin PB, Gravenstein N, Doyle TJ, Roberts SA, Skinner S, Langevin SO, et al. Growth of Staphylococcus aureus in Diprivan and Intralipid: Implications on the pathogenesis of infections. Anesthesiology 1999;91(5):1394–400. 10. Sosis MB, Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg. 1993;77(4):766–8.